Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Dara Aisner

Concepts (418)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
69
2026
2637
4.840
 Why?
Carcinoma, Non-Small-Cell Lung
48
2026
1180
3.860
 Why?
ErbB Receptors
22
2025
627
2.140
 Why?
Genetic Testing
9
2022
478
2.130
 Why?
Mutation
42
2026
4089
2.010
 Why?
Pathology, Molecular
7
2019
25
1.940
 Why?
High-Throughput Nucleotide Sequencing
16
2026
549
1.890
 Why?
Oncogene Proteins, Fusion
13
2019
210
1.810
 Why?
Protein Kinase Inhibitors
27
2026
969
1.790
 Why?
Molecular Diagnostic Techniques
3
2020
104
1.500
 Why?
Proto-Oncogene Proteins B-raf
13
2022
225
1.320
 Why?
Proto-Oncogene Proteins
17
2018
623
1.310
 Why?
Biomarkers, Tumor
21
2026
1313
1.290
 Why?
Neoplasms
13
2025
2875
1.280
 Why?
Protein-Tyrosine Kinases
12
2018
433
1.270
 Why?
Receptor Protein-Tyrosine Kinases
10
2019
230
1.020
 Why?
DNA, Neoplasm
3
2019
163
1.010
 Why?
Antineoplastic Agents
16
2024
2194
0.990
 Why?
Proto-Oncogene Proteins p21(ras)
11
2020
253
0.970
 Why?
Proto-Oncogene Proteins c-met
5
2019
75
0.870
 Why?
Drug Resistance, Neoplasm
13
2023
881
0.840
 Why?
Gene Rearrangement
14
2026
155
0.820
 Why?
Acrylamides
5
2025
70
0.770
 Why?
Molecular Targeted Therapy
12
2026
432
0.750
 Why?
Colorectal Neoplasms
3
2022
845
0.740
 Why?
Adenocarcinoma
9
2018
928
0.730
 Why?
Ganglioglioma
4
2014
34
0.700
 Why?
Brain Neoplasms
10
2018
1318
0.670
 Why?
DNA Mutational Analysis
11
2020
406
0.670
 Why?
Immunohistochemistry
11
2026
1716
0.650
 Why?
Aniline Compounds
4
2025
119
0.640
 Why?
Tumor Suppressor Protein p53
4
2026
529
0.640
 Why?
Humans
128
2026
144759
0.630
 Why?
Precision Medicine
4
2018
457
0.610
 Why?
Prognosis
15
2026
4282
0.610
 Why?
Adenocarcinoma, Mucinous
2
2022
76
0.600
 Why?
Insurance, Health, Reimbursement
1
2020
96
0.600
 Why?
Neoplasms, Muscle Tissue
1
2019
3
0.600
 Why?
Receptors, Nerve Growth Factor
1
2019
18
0.590
 Why?
Pyrazoles
10
2018
509
0.580
 Why?
Biological Products
1
2022
252
0.580
 Why?
Astrocytoma
3
2015
129
0.580
 Why?
Neoplasm Metastasis
10
2024
688
0.570
 Why?
Insurance Coverage
1
2020
239
0.560
 Why?
Antineoplastic Combined Chemotherapy Protocols
7
2024
1953
0.540
 Why?
In Situ Hybridization, Fluorescence
13
2019
322
0.540
 Why?
Laboratory Proficiency Testing
2
2023
9
0.530
 Why?
Computational Biology
4
2023
680
0.500
 Why?
Medical Oncology
5
2026
332
0.480
 Why?
RNA
5
2019
940
0.460
 Why?
Pyrimidines
7
2025
532
0.430
 Why?
Smoking
3
2018
1472
0.430
 Why?
Neoplasm Staging
13
2024
1462
0.420
 Why?
Small Cell Lung Carcinoma
1
2016
119
0.420
 Why?
Aged, 80 and over
19
2026
8265
0.420
 Why?
ras Proteins
5
2015
150
0.410
 Why?
Mesothelioma
2
2024
48
0.390
 Why?
DNA Copy Number Variations
6
2026
183
0.380
 Why?
Pyridines
8
2016
605
0.380
 Why?
Aged
34
2026
25913
0.370
 Why?
AMP-Activated Protein Kinases
1
2014
190
0.370
 Why?
Neoplasm Recurrence, Local
3
2022
1137
0.370
 Why?
Endometrial Neoplasms
2
2026
208
0.370
 Why?
Female
55
2026
78271
0.350
 Why?
Laboratories
3
2025
109
0.340
 Why?
Middle Aged
42
2026
35875
0.340
 Why?
Male
53
2026
72315
0.340
 Why?
Telomerase
7
2002
248
0.340
 Why?
S100 Proteins
2
2014
36
0.340
 Why?
B7-H1 Antigen
2
2026
241
0.320
 Why?
Pleural Neoplasms
2
2024
27
0.320
 Why?
TOR Serine-Threonine Kinases
1
2014
449
0.320
 Why?
Neoadjuvant Therapy
3
2024
462
0.320
 Why?
Genomics
4
2023
834
0.310
 Why?
Sulfones
3
2015
127
0.300
 Why?
Glycine
3
2015
187
0.290
 Why?
Adult
37
2026
40449
0.280
 Why?
Curriculum
1
2016
1059
0.280
 Why?
Early Detection of Cancer
2
2019
463
0.280
 Why?
Adrenal Gland Neoplasms
2
2022
91
0.270
 Why?
Head and Neck Neoplasms
3
2019
558
0.260
 Why?
Indoles
6
2025
501
0.260
 Why?
Neoplasms, Multiple Primary
2
2022
58
0.260
 Why?
Oncogene Fusion
2
2019
11
0.250
 Why?
Gene Dosage
2
2018
148
0.250
 Why?
Class I Phosphatidylinositol 3-Kinases
4
2022
108
0.250
 Why?
Receptor, Fibroblast Growth Factor, Type 1
2
2018
58
0.250
 Why?
Exons
5
2019
358
0.240
 Why?
Melanoma
2
2020
761
0.240
 Why?
Treatment Outcome
12
2024
11679
0.240
 Why?
Survival Analysis
5
2025
1382
0.240
 Why?
Antineoplastic Agents, Immunological
2
2018
199
0.240
 Why?
Genetic Predisposition to Disease
6
2019
2363
0.230
 Why?
Phosphatidylinositol 3-Kinases
4
2023
380
0.230
 Why?
Oncogenes
3
2016
119
0.230
 Why?
Sodium-Phosphate Cotransporter Proteins, Type IIb
3
2015
8
0.230
 Why?
Thymus Neoplasms
1
2025
27
0.230
 Why?
Thymoma
1
2025
36
0.220
 Why?
Pemetrexed
1
2024
38
0.220
 Why?
Epithelioid Cells
2
2015
9
0.220
 Why?
Immunotherapy
5
2022
653
0.210
 Why?
Fetomaternal Transfusion
1
2023
10
0.200
 Why?
Sensitivity and Specificity
5
2019
1985
0.200
 Why?
Carcinoma, Squamous Cell
3
2019
641
0.200
 Why?
Endodermal Sinus Tumor
1
2022
8
0.190
 Why?
Choriocarcinoma
1
2022
9
0.190
 Why?
Tertiary Care Centers
1
2023
189
0.180
 Why?
Pathologists
2
2023
19
0.180
 Why?
Cell Line, Tumor
11
2018
3540
0.180
 Why?
Biopsy, Fine-Needle
2
2012
68
0.180
 Why?
Gene Fusion
2
2018
29
0.180
 Why?
Goals
1
2023
183
0.180
 Why?
Young Adult
13
2024
14105
0.170
 Why?
Cell Proliferation
7
2017
2496
0.170
 Why?
Patient Selection
4
2018
719
0.170
 Why?
Neoplasms, Germ Cell and Embryonal
1
2022
75
0.170
 Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
2022
40
0.170
 Why?
Hematologic Neoplasms
1
2023
161
0.170
 Why?
Biopsy
4
2018
1075
0.170
 Why?
Carbazoles
1
2021
56
0.170
 Why?
Graft vs Host Disease
1
2023
264
0.170
 Why?
Pheochromocytoma
1
2022
58
0.170
 Why?
Combined Modality Therapy
4
2018
1266
0.170
 Why?
United States
10
2025
15966
0.170
 Why?
Meningioma
1
2022
87
0.160
 Why?
Trastuzumab
1
2021
118
0.160
 Why?
Laboratories, Hospital
1
2020
13
0.160
 Why?
Glioblastoma
2
2015
353
0.160
 Why?
Government Regulation
1
2020
38
0.160
 Why?
Pathology, Clinical
2
2017
29
0.160
 Why?
GTP Phosphohydrolases
1
2020
93
0.160
 Why?
Piperidines
1
2021
217
0.150
 Why?
Costs and Cost Analysis
1
2020
219
0.150
 Why?
Stakeholder Participation
1
2020
84
0.150
 Why?
Cell Transformation, Neoplastic
3
2018
339
0.150
 Why?
Endoscopic Ultrasound-Guided Fine Needle Aspiration
2
2017
59
0.150
 Why?
Chromosome Aberrations
2
2019
162
0.150
 Why?
Genes, erbB-2
2
2015
33
0.150
 Why?
Smad4 Protein
1
2019
34
0.140
 Why?
Multiplex Polymerase Chain Reaction
1
2019
53
0.140
 Why?
Genetic Heterogeneity
1
2019
62
0.140
 Why?
Multigene Family
1
2019
204
0.140
 Why?
Breast Neoplasms, Male
1
2018
29
0.140
 Why?
Genetic Markers
1
2019
331
0.140
 Why?
Pyridazines
1
2018
57
0.140
 Why?
Retrospective Studies
12
2026
17066
0.140
 Why?
Database Management Systems
1
2018
50
0.140
 Why?
Genetic Association Studies
1
2019
372
0.130
 Why?
Gene Frequency
1
2019
481
0.130
 Why?
Cell Cycle Proteins
4
2015
628
0.130
 Why?
Piperazines
2
2018
381
0.130
 Why?
Quinazolines
3
2014
266
0.130
 Why?
Thromboembolism
1
2018
125
0.130
 Why?
Cell-Free Nucleic Acids
1
2018
33
0.130
 Why?
Pregnancy Complications
1
2023
592
0.130
 Why?
Skin Neoplasms
2
2020
847
0.130
 Why?
Programmed Cell Death 1 Receptor
2
2018
264
0.130
 Why?
Smokers
1
2018
137
0.130
 Why?
Gene Deletion
1
2019
389
0.130
 Why?
Radiotherapy, Intensity-Modulated
1
2018
141
0.130
 Why?
Medical Informatics
1
2018
97
0.130
 Why?
Imidazoles
1
2018
254
0.130
 Why?
Intraoperative Care
1
2017
62
0.130
 Why?
Leukemia, Myeloid, Acute
1
2024
682
0.130
 Why?
Chloroquine
1
2017
53
0.130
 Why?
Ovarian Neoplasms
1
2022
586
0.120
 Why?
Pleural Effusion, Malignant
1
2016
12
0.120
 Why?
Coculture Techniques
1
2017
246
0.120
 Why?
Small Molecule Libraries
1
2017
111
0.120
 Why?
Disease Progression
6
2024
2847
0.120
 Why?
Carcinogenesis
1
2017
229
0.120
 Why?
Immunity, Humoral
1
2016
120
0.120
 Why?
Proto-Oncogene Proteins c-kit
1
2016
72
0.120
 Why?
Codon
1
2016
94
0.120
 Why?
Clinical Decision-Making
1
2019
359
0.120
 Why?
Sulfonamides
2
2017
580
0.120
 Why?
Survival Rate
5
2026
2089
0.110
 Why?
RNA, Messenger
4
2018
2832
0.110
 Why?
Neoplastic Cells, Circulating
1
2016
81
0.110
 Why?
Triple Negative Breast Neoplasms
1
2018
215
0.110
 Why?
Protein Kinases
1
2017
315
0.110
 Why?
Fatal Outcome
1
2016
307
0.110
 Why?
Clinical Laboratory Techniques
1
2016
96
0.110
 Why?
Peritoneal Neoplasms
1
2016
103
0.110
 Why?
Oncogene Proteins
1
2015
61
0.110
 Why?
Positron Emission Tomography Computed Tomography
1
2016
117
0.110
 Why?
Amino Acid Substitution
1
2016
304
0.110
 Why?
Signal Transduction
5
2017
5226
0.110
 Why?
Immunity, Cellular
1
2016
272
0.110
 Why?
Sequence Analysis, RNA
1
2017
442
0.110
 Why?
Practice Guidelines as Topic
2
2019
1560
0.110
 Why?
Hamartoma
1
2015
29
0.110
 Why?
Genetic Variation
1
2019
983
0.110
 Why?
Pharmacogenetics
1
2016
172
0.110
 Why?
Meningeal Carcinomatosis
1
2014
7
0.110
 Why?
Spinal Cord Neoplasms
1
2014
41
0.110
 Why?
Health Care Surveys
1
2016
539
0.110
 Why?
Autophagy
1
2017
286
0.110
 Why?
Medicare
1
2020
886
0.100
 Why?
Speech Disorders
1
2014
29
0.100
 Why?
Mitogen-Activated Protein Kinases
1
2015
292
0.100
 Why?
Paresis
1
2014
30
0.100
 Why?
Deoxycytidine
1
2015
221
0.100
 Why?
Receptor, trkA
1
2013
15
0.100
 Why?
Multimodal Imaging
1
2015
124
0.100
 Why?
Tumor Cells, Cultured
5
2019
919
0.100
 Why?
Polymerase Chain Reaction
2
2014
1054
0.100
 Why?
Membrane Proteins
1
2020
1166
0.100
 Why?
Alternative Splicing
3
2017
247
0.100
 Why?
Liver Neoplasms
3
2015
780
0.100
 Why?
Microscopy, Electron
1
2014
415
0.100
 Why?
Dose-Response Relationship, Drug
5
2021
2027
0.100
 Why?
Wnt Signaling Pathway
1
2015
210
0.100
 Why?
Intracranial Hemorrhages
1
2014
100
0.100
 Why?
Graft Rejection
1
2016
540
0.100
 Why?
Lung Transplantation
1
2016
338
0.100
 Why?
Positron-Emission Tomography
1
2015
323
0.100
 Why?
Brain Stem Neoplasms
1
2013
87
0.100
 Why?
Serine Endopeptidases
1
2013
128
0.100
 Why?
Headache
1
2014
150
0.090
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2017
983
0.090
 Why?
Sarcoma
1
2015
205
0.090
 Why?
Gene Expression Regulation, Neoplastic
1
2019
1455
0.090
 Why?
Bone Neoplasms
1
2015
253
0.090
 Why?
Societies, Medical
4
2018
887
0.090
 Why?
Microtubule-Associated Proteins
1
2013
196
0.090
 Why?
Tissue Fixation
1
2012
36
0.090
 Why?
Recombinant Fusion Proteins
2
2013
675
0.090
 Why?
Gene Amplification
3
2019
120
0.090
 Why?
Mutation Rate
1
2011
30
0.090
 Why?
Predictive Value of Tests
2
2015
2115
0.090
 Why?
Translocation, Genetic
1
2012
115
0.090
 Why?
Lung
4
2015
4109
0.090
 Why?
Algorithms
1
2019
1837
0.080
 Why?
Interdisciplinary Communication
1
2012
197
0.080
 Why?
Tomography, X-Ray Computed
3
2018
2730
0.080
 Why?
Education, Medical, Graduate
1
2016
557
0.080
 Why?
Clinical Trials as Topic
3
2025
1053
0.080
 Why?
Teratoma
1
2011
120
0.080
 Why?
Specimen Handling
1
2012
186
0.080
 Why?
Epithelial Cells
1
2017
1125
0.080
 Why?
Rhabdoid Tumor
1
2011
103
0.080
 Why?
DNA-Binding Proteins
6
2011
1499
0.080
 Why?
Genome, Human
1
2012
422
0.080
 Why?
Terminology as Topic
1
2012
255
0.080
 Why?
Prospective Studies
2
2023
7990
0.080
 Why?
Immunoenzyme Techniques
3
2015
200
0.080
 Why?
Phosphorylation
1
2014
1732
0.080
 Why?
Erlotinib Hydrochloride
3
2014
72
0.070
 Why?
Xenograft Model Antitumor Assays
3
2019
928
0.070
 Why?
Breast Neoplasms
1
2022
2452
0.070
 Why?
Disease-Free Survival
3
2016
769
0.070
 Why?
Catheter Ablation
1
2012
353
0.070
 Why?
Leukemia-Lymphoma, Adult T-Cell
1
2008
17
0.070
 Why?
Diagnosis, Differential
1
2012
1489
0.070
 Why?
Proto-Oncogene Proteins c-ret
2
2018
40
0.070
 Why?
Telomere
3
2000
288
0.070
 Why?
beta Catenin
2
2023
252
0.070
 Why?
Hematopoietic Stem Cell Transplantation
2
2024
675
0.070
 Why?
Maximum Tolerated Dose
2
2021
212
0.070
 Why?
Heart Neoplasms
1
2008
55
0.070
 Why?
Follow-Up Studies
4
2021
5408
0.070
 Why?
DNA
1
2014
1463
0.060
 Why?
Pancreatic Neoplasms
1
2015
919
0.060
 Why?
Adolescent
6
2019
22428
0.060
 Why?
Reproducibility of Results
3
2019
3409
0.060
 Why?
Workflow
2
2017
184
0.060
 Why?
Eye Neoplasms
1
2005
30
0.060
 Why?
National Cancer Institute (U.S.)
1
2025
52
0.060
 Why?
Myasthenia Gravis
1
2025
23
0.060
 Why?
Internship and Residency
1
2016
1257
0.060
 Why?
Mental Disorders
1
2014
1168
0.050
 Why?
Polymorphism, Single Nucleotide
2
2025
2145
0.050
 Why?
Pleura
1
2024
28
0.050
 Why?
Immunophenotyping
1
2005
322
0.050
 Why?
DNA Polymerase II
1
2023
35
0.050
 Why?
Poly-ADP-Ribose Binding Proteins
1
2023
36
0.050
 Why?
Induction Chemotherapy
1
2024
87
0.050
 Why?
Administration, Oral
2
2018
847
0.050
 Why?
Real-Time Polymerase Chain Reaction
2
2015
341
0.050
 Why?
Genes, ras
2
2015
96
0.050
 Why?
Peritoneum
1
2023
45
0.050
 Why?
DNA Mismatch Repair
1
2023
52
0.050
 Why?
Leukocyte Count
1
2024
316
0.050
 Why?
Antigens, Differentiation, B-Lymphocyte
2
2013
37
0.050
 Why?
Blotting, Western
4
2015
1187
0.050
 Why?
Carcinoma, Endometrioid
1
2022
51
0.050
 Why?
Cell Survival
2
2017
1098
0.040
 Why?
Cell Cycle
2
2012
596
0.040
 Why?
Active Transport, Cell Nucleus
1
2002
121
0.040
 Why?
Histocompatibility Antigens Class II
2
2013
364
0.040
 Why?
Magnetic Resonance Imaging
1
2014
3863
0.040
 Why?
Gene Expression Regulation, Enzymologic
1
2002
269
0.040
 Why?
Gene Expression Profiling
2
2017
1782
0.040
 Why?
Models, Molecular
2
2018
1618
0.040
 Why?
Base Sequence
3
2017
2190
0.040
 Why?
Standard of Care
1
2020
80
0.040
 Why?
Mice
3
2026
18339
0.040
 Why?
Animals
6
2026
38058
0.040
 Why?
Protein Processing, Post-Translational
1
2002
477
0.040
 Why?
HSP90 Heat-Shock Proteins
1
1999
47
0.040
 Why?
Catalytic Domain
4
2000
232
0.040
 Why?
Fetus
1
2023
803
0.040
 Why?
Time Factors
3
2020
7173
0.040
 Why?
Cell Nucleus
1
2002
618
0.040
 Why?
Sequence Deletion
2
2014
193
0.030
 Why?
Aurora Kinase A
1
2018
62
0.030
 Why?
Radiotherapy, Image-Guided
1
2018
39
0.030
 Why?
Tumor Microenvironment
1
2023
732
0.030
 Why?
Cell Line
4
2012
2882
0.030
 Why?
Proto-Oncogenes
1
2018
29
0.030
 Why?
RNA, Untranslated
1
1999
124
0.030
 Why?
Cohort Studies
2
2019
5960
0.030
 Why?
Nausea
1
2018
111
0.030
 Why?
Cetuximab
1
2018
111
0.030
 Why?
Phthalazines
1
2018
64
0.030
 Why?
Receptor, Fibroblast Growth Factor, Type 2
1
2017
28
0.030
 Why?
Breast
1
2018
158
0.030
 Why?
Diarrhea
1
2018
192
0.030
 Why?
Quality Control
1
2017
163
0.030
 Why?
Molecular Sequence Data
3
2013
2930
0.030
 Why?
A549 Cells
1
2017
75
0.030
 Why?
Pathology, Surgical
1
2016
6
0.030
 Why?
Child
5
2015
22633
0.030
 Why?
Structure-Activity Relationship
1
2018
570
0.030
 Why?
Risk Assessment
1
2026
3671
0.030
 Why?
Centrosome
1
2016
71
0.030
 Why?
Drug Synergism
1
2017
357
0.030
 Why?
Carcinoma
2
2012
228
0.030
 Why?
Fatigue
1
2018
366
0.030
 Why?
Dual Specificity Phosphatase 6
1
2015
5
0.030
 Why?
Consensus
1
2018
488
0.030
 Why?
Genes, erbB-1
1
2015
21
0.030
 Why?
Mice, Nude
1
2017
682
0.030
 Why?
Lamin Type A
1
2015
51
0.030
 Why?
Cell Line, Transformed
3
2000
140
0.030
 Why?
Transcription, Genetic
1
2002
1496
0.030
 Why?
Mitogen-Activated Protein Kinase Kinases
1
2015
128
0.030
 Why?
MAP Kinase Kinase 1
1
2015
71
0.030
 Why?
Multivariate Analysis
1
2018
1539
0.030
 Why?
Antimetabolites, Antineoplastic
1
2015
105
0.030
 Why?
Child, Preschool
3
2015
11787
0.030
 Why?
HEK293 Cells
1
2017
744
0.030
 Why?
Sequence Analysis, DNA
1
2017
824
0.030
 Why?
Respiratory Mucosa
1
2017
322
0.030
 Why?
Radiopharmaceuticals
1
2015
194
0.030
 Why?
Fluorodeoxyglucose F18
1
2015
156
0.030
 Why?
Intercellular Signaling Peptides and Proteins
1
2015
381
0.030
 Why?
Recurrence
1
2017
1135
0.020
 Why?
Microdissection
1
2013
15
0.020
 Why?
Epidermal Growth Factor
1
2013
171
0.020
 Why?
Drug Administration Schedule
1
2015
779
0.020
 Why?
Disease Management
1
2017
645
0.020
 Why?
Syndecan-4
1
2012
6
0.020
 Why?
Proto-Oncogene Proteins c-akt
1
2015
436
0.020
 Why?
Papillomaviridae
1
2013
115
0.020
 Why?
Antibodies, Monoclonal, Humanized
1
2018
985
0.020
 Why?
Cooperative Behavior
1
2015
465
0.020
 Why?
Bone and Bones
1
2015
314
0.020
 Why?
Randomized Controlled Trials as Topic
1
2018
1720
0.020
 Why?
SMARCB1 Protein
1
2011
34
0.020
 Why?
Transcriptome
1
2018
1045
0.020
 Why?
Incidence
1
2018
2879
0.020
 Why?
Hyperglycemia
1
2015
375
0.020
 Why?
Green Fluorescent Proteins
1
2012
405
0.020
 Why?
Chromosomal Proteins, Non-Histone
1
2011
132
0.020
 Why?
Lymphatic Metastasis
1
2012
333
0.020
 Why?
Bronchoscopy
1
2012
227
0.020
 Why?
Adaptor Proteins, Signal Transducing
1
2013
427
0.020
 Why?
Enzyme Inhibitors
1
2014
824
0.020
 Why?
Pregnancy
1
2023
7190
0.020
 Why?
Infant
2
2015
10034
0.020
 Why?
Cognition Disorders
1
2014
538
0.020
 Why?
Retroviridae
2
2000
101
0.020
 Why?
Reticulocytes
2
1999
17
0.020
 Why?
Hypertension
1
2018
1263
0.020
 Why?
Protein Structure, Tertiary
1
2012
862
0.020
 Why?
Cells, Cultured
1
2017
4154
0.020
 Why?
Sex Factors
1
2015
2112
0.020
 Why?
Papillomavirus Infections
1
2013
345
0.020
 Why?
Leukemic Infiltration
1
2008
11
0.020
 Why?
Genetic Vectors
2
2000
337
0.020
 Why?
DNA Primers
2
1999
512
0.020
 Why?
Human T-lymphotropic virus 1
1
2008
32
0.020
 Why?
Rabbits
2
1999
648
0.020
 Why?
Longitudinal Studies
1
2015
2947
0.020
 Why?
In Vitro Techniques
2
1999
1047
0.020
 Why?
T-Lymphocytes
1
2016
1982
0.020
 Why?
National Institutes of Health (U.S.)
1
2008
140
0.020
 Why?
Phenotype
1
2015
3162
0.020
 Why?
Apoptosis
1
2015
2430
0.020
 Why?
Biomarkers
1
2017
4271
0.010
 Why?
Fibroblasts
2
2000
1034
0.010
 Why?
Transcription Factors
1
2011
1741
0.010
 Why?
Infant, Newborn
1
2013
6429
0.010
 Why?
Peptide Chain Termination, Translational
1
2000
9
0.010
 Why?
Fetal Proteins
1
2000
15
0.010
 Why?
Genes, Dominant
1
2000
101
0.010
 Why?
Chromosomes, Human
1
2000
41
0.010
 Why?
Fibrosarcoma
1
2000
23
0.010
 Why?
DNA, Complementary
1
2000
276
0.010
 Why?
Protein Subunits
1
2000
226
0.010
 Why?
Quinones
1
1999
8
0.010
 Why?
RNA-Directed DNA Polymerase
1
1999
35
0.010
 Why?
Lactams, Macrocyclic
1
1999
51
0.010
 Why?
Benzoquinones
1
1999
47
0.010
 Why?
Transfection
1
2000
940
0.010
 Why?
Cyclosporine
1
1999
265
0.010
 Why?
Carcinoma, Renal Cell
1
2000
234
0.010
 Why?
Half-Life
1
1997
151
0.010
 Why?
Neoplasm Proteins
1
2000
442
0.010
 Why?
Molecular Chaperones
1
1999
200
0.010
 Why?
RNA, Long Noncoding
1
1999
177
0.010
 Why?
Adenosine Triphosphate
1
1999
498
0.010
 Why?
Recombinant Proteins
1
1999
1370
0.010
 Why?
Skin
1
2000
755
0.010
 Why?
Flow Cytometry
1
1997
1173
0.010
 Why?
Prostatic Neoplasms
1
2000
974
0.010
 Why?
Aisner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (418) concept(s)
_
Co-Authors Expand Description
See all (83) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)